Cargando…

Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy

In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Yang, Yushan, Huang, Li, Liu, Ying, Chong, Gaowei, Yin, Weimin, Dong, Haiqing, Li, Yan, Li, Yongyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024915/
https://www.ncbi.nlm.nih.gov/pubmed/35456568
http://dx.doi.org/10.3390/pharmaceutics14040734
_version_ 1784690731109056512
author Zhang, Tingting
Yang, Yushan
Huang, Li
Liu, Ying
Chong, Gaowei
Yin, Weimin
Dong, Haiqing
Li, Yan
Li, Yongyong
author_facet Zhang, Tingting
Yang, Yushan
Huang, Li
Liu, Ying
Chong, Gaowei
Yin, Weimin
Dong, Haiqing
Li, Yan
Li, Yongyong
author_sort Zhang, Tingting
collection PubMed
description In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. These strategies either utilize biomimetic materials, as building blocks to construct inanimate entities whose functions are similar to natural living cells, or engineer immune cells with functional materials, to potentiate their anti-tumor effects. In this review, we will summarize these advanced strategies in different cell types, as well as discussing the prospects of this field.
format Online
Article
Text
id pubmed-9024915
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90249152022-04-23 Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy Zhang, Tingting Yang, Yushan Huang, Li Liu, Ying Chong, Gaowei Yin, Weimin Dong, Haiqing Li, Yan Li, Yongyong Pharmaceutics Review In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. These strategies either utilize biomimetic materials, as building blocks to construct inanimate entities whose functions are similar to natural living cells, or engineer immune cells with functional materials, to potentiate their anti-tumor effects. In this review, we will summarize these advanced strategies in different cell types, as well as discussing the prospects of this field. MDPI 2022-03-29 /pmc/articles/PMC9024915/ /pubmed/35456568 http://dx.doi.org/10.3390/pharmaceutics14040734 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zhang, Tingting
Yang, Yushan
Huang, Li
Liu, Ying
Chong, Gaowei
Yin, Weimin
Dong, Haiqing
Li, Yan
Li, Yongyong
Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
title Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
title_full Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
title_fullStr Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
title_full_unstemmed Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
title_short Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
title_sort biomimetic and materials-potentiated cell engineering for cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024915/
https://www.ncbi.nlm.nih.gov/pubmed/35456568
http://dx.doi.org/10.3390/pharmaceutics14040734
work_keys_str_mv AT zhangtingting biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT yangyushan biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT huangli biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT liuying biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT chonggaowei biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT yinweimin biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT donghaiqing biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT liyan biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy
AT liyongyong biomimeticandmaterialspotentiatedcellengineeringforcancerimmunotherapy